US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

IDEXX Laboratories, Inc.

us-stock
To Invest in {{usstockname}}
us-stock
$724.5 -0.0093(-0.93%) IDXX at 04 Dec 2025 04:34 PM Diagnostics & Research
Lowest Today 724.78
Highest Today 739.145
Today’s Open 737.285
Prev. Close 732.73
52 Week High 769.98
52 Week Low 356.14
Day’s Range: Low 724.78 High 739.145
52-Week Range: Low 356.14 High 769.98
1 day return -
1 Week return -3.67
1 month return +0.49
3 month return +13.32
6 month return +38.24
1 year return +67.12
3 year return +71.88
5 year return +58.77
10 year return -

Institutional Holdings

Vanguard Group Inc 12.34

BlackRock Inc 10.47

State Street Corp 4.44

Fundsmith LLP 3.30

Vanguard Total Stock Mkt Idx Inv 3.16

Fundsmith Equity I Acc 3.15

Geode Capital Management, LLC 3.08

BAMCO Inc 2.54

Vanguard 500 Index Investor 2.49

Vanguard Mid Cap Index Institutional 2.24

Morgan Stanley - Brokerage Accounts 2.08

Invesco QQQ Trust 2.07

Bank of New York Mellon Corp 1.81

Polen Capital 1.49

Amvescap Plc. 1.45

Principal Financial Group Inc 1.41

Blair William & Co 1.35

UBS Asset Mgmt Americas Inc 1.34

Fidelity 500 Index 1.27

SPDR® S&P 500® ETF 1.21

iShares Core S&P 500 ETF 1.21

Northern Trust Corp 1.20

Vanguard Growth Index Investor 1.14

American Century Companies Inc 1.07

FUNDSMITH INVESTMENT SERVICES LTD. 1.06

Principal MidCap R5 0.88

William Blair Investment Management, LLC 0.86

Capital Research Global Investors 0.86

Amundi 0.84

Vanguard Mid-Cap Growth ETF 0.84

American Funds AMCAP A 0.83

Capital Group AMCAP Composite 0.83

Legal & General Group PLC 0.81

Baron Partners Retail 0.78

Principal Aligned MidCap Equity 0.71

The Health Care Select Sector SPDR® ETF 0.69

iShares Russell Mid-Cap Growth ETF 0.66

Baron Asset Retail 0.61

Baron Mid Cap Growth Strategy 0.61

Vanguard Institutional Index I 0.61

Market Status

Strong Buy: 3

Buy: 3

Hold: 6

Sell: 1

Strong Sell: 0

Fundamentals

Market Cap 58621.84 M

PB Ratio 37.2853

PE Ratio 57.7863

Enterprise Value 59114.02 M

Total Assets 3293.44 M

Volume 505139

Company Financials

Annual Revenue FY24:3897504000 3897.5M, FY23:3587920000 3587.9M, FY22:3367324000 3367.3M, FY21:3215360000 3215.4M, FY20:2706655000 2706.7M

Annual Profit FY24:2378927000 2378.9M, FY23:2148730000 2148.7M, FY22:2004338000 2004.3M, FY21:1889432000 1889.4M, FY20:1571040000 1571.0M

Annual Net worth FY24:887867000 887.9M, FY23:822728000 822.7M, FY22:679089000 679.1M, FY21:744845000 744.8M, FY20:581776000 581.8M

Quarterly Revenue Q3/2025:1105239000 1105.2M, Q2/2025:1109457000 1109.5M, Q1/2025:998427000 998.4M, Q4/2024:954288000 954.3M, Q3/2024:975543000 975.5M

Quarterly Profit Q3/2025:683354000 683.4M, Q2/2025:694732000 694.7M, Q1/2025:623379000 623.4M, Q4/2024:570660000 570.7M, Q3/2024:596038000 596.0M

Quarterly Net worth Q3/2025:274610000 274.6M, Q2/2025:293989000 294.0M, Q1/2025:242677000 242.7M, Q4/2024:216149000 216.1M, Q3/2024:232841000 232.8M

Fund house & investment objective

Company Information IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Organisation Diagnostics & Research

Employees 11000

Industry Diagnostics & Research

CEO Mr. Jonathan J. Mazelsky

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right